| Revenue growth | Full year revenue reached ₹67,137 million with pharma growing 40%. |
|---|---|
| Margins | EBITDA margins maintained at 25% despite pricing pressures. |
| Order book | Agchem order book remains robust at approximately $1.2 billion. |
| Demand visibility | Muted near-term global demand; expected recovery in upcoming Kharif season. |
| Management confidence | Confident but realistic about navigating the global agrochemical downcycle. |
Growth
Revenue grew to ₹67,137 million with steady 25% EBITDA margins. Growth was volume-led in Pharma (40%) but offset by global agrochemical headwinds.
Outlook
Guided for positive revenue growth in FY27. Projecting $100M revenue from electronic chemicals in 4-5 years.
Risks
High concentration in a single molecule; global agrochemical oversupply; rising R&D and launch costs for new entities.
Earnings Call filed with BSE, NSE: PIIND. Summary written with AI assistance from the document.
PI Industries Ltd: key numbers
- Share price
- ₹2,205.80
- Market cap
- ₹33,466 Cr
- Revenue (annual)
- ₹6,714 Cr
- Net profit (annual)
- ₹1,321 Cr
- P/E (TTM)
- 28.7×Sector 37.2×
- Promoter holding
- 46.09%+0.00% QoQ
- FII holding
- 14.83%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from PI Industries Ltd
All →PI Industries Other Announcement
Bhavina J Dholariya, an immediate relative of an insider, sold equity shares of PI Industries Ltd. The market sale was valued at ₹0.12 Crore.
- Value
- ₹0.12 Cr
PI Industries Product Launch
PI Industries received registration for its indigenously developed insecticide, 'Pioxaniliprole' (branded 'Pioxazon'), marking a key milestone in its agricultural innovation journey.
PI Industries Other Announcement
Designated person Jayesh Dholariya disclosed the sale of 3,000 equity shares via gift, totaling approximately Rs. 0.75 Crore.
- Value
- ₹0.75 Cr
PI Industries Annual General Meeting
PI Industries held its 79th Annual General Meeting on August 14, 2026. Shareholders approved all nine agenda items, including financial statements and dividend payments.
PI Industries Earnings Call Transcript: Key Takeaways
PI Industries Q1 FY27 results show resilience amidst global agrochemical headwinds, maintaining healthy EBITDA margins at 22% despite revenue softness. Management remains optimistic about a second-half recovery driven by domestic monsoon improvement and new product scale-ups.
- Call
- Guides 5% growth
PI Industries Investor Presentation: Key Takeaways
PI Industries Q1 FY27 consolidated revenue fell 10% to ₹17,023 Mn, with EBITDA down 29% and PAT down 39% due to global agrochemical headwinds and cyclical disruptions.